Serine Hydroxy-methyltransferases Antibodies

Santa Cruz Biotechnology delivers a wide array of Serine Hydroxy-methyltransferases monoclonal antibodies for advancing research in understanding critical enzyme functions. Serine Hydroxy-methyltransferases Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Serine hydroxy-methyltransferases are essential enzymes involved in the metabolism of serine and glycine, playing a significant role in one-carbon metabolism and nucleotide synthesis. Their function is crucial for cellular proliferation and maintaining the balance of methylation processes, which are vital for gene expression regulation and epigenetic modifications. Dysregulation of serine hydroxy-methyltransferases has been implicated in various diseases, including cancer, making them important targets for therapeutic intervention. Researchers can explore cellular pathways and molecular mechanisms using specific detection methods with conjugated fluorophores such as phycoerythrin (PE), fluorescein isothiocyanate (FITC), or horseradish peroxidase (HRP). Understanding serine hydroxy-methyltransferases function and regulation contributes to developing new therapeutic strategies. Santa Cruz Biotechnology monoclonal antibodies for serine hydroxy-methyltransferases support researchers worldwide in advancing scientific knowledge and potential therapeutic discoveries.